Earlitec Diagnostics

Earlitec Diagnostics has 2 AI-enabled medical devices on the FDA list. The first decision was on March 26, 2025 and the most recent on March 5, 2026 (EarliPoint Assessment). Its most common review panel is Neurology (2 devices).